Clinical Trial Update: PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of PF-00299804 in patients with metastatic or recurrent head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PF-00299804

Snippet

Sponsor: Yonsei University | Conditions: Head Neck Cancer Squamous Cell Metastatic, Head Neck Cancer Squamous Cell Recurrent | Phase 2 | Status: COMPLETED